4.6 Review

The Roles of Exosomal microRNAs in Diffuse Large B-Cell Lymphoma: Diagnosis, Prognosis, Clinical Application, and Biomolecular Mechanisms

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Circulating exosomal microRNAs as diagnostic and prognostic biomarkers in patients with diffuse large B-cell lymphoma

Di Cao et al.

Summary: Exosomal microRNAs have potential as biomarkers for DLBCL diagnosis and prognosis, with miR-451a showing significant associations with both progression-free survival and overall survival in DLBCL patients, particularly when combined with the international prognostic index. Circulating exosomal microRNAs may improve the identification of DLBCL patients with poor outcomes.

HEMATOLOGICAL ONCOLOGY (2022)

Article Hematology

Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma

Matias Autio et al.

Summary: The study characterized the immunological profile of DLBCL TME using Nanostring platform and multiplex immunohistochemistry, revealing high heterogeneity at the transcriptome level. A high proportion of immune checkpoint positive T cells in the tumor microenvironment was associated with unfavorable survival outcomes.

HAEMATOLOGICA (2021)

Review Oncology

Diffuse large B-cell lymphoma: new targets and novel therapies

Bruce D. Cheson et al.

Summary: Newer, more effective and non-cytotoxic therapies are needed for patients with DLBCL and other B-cell malignancies. Approved treatments include various combinations of drugs, CAR-T cell products, and ongoing development of other therapies. Combinations of targeted therapies are expected to further improve the outcomes for patients.

BLOOD CANCER JOURNAL (2021)

Article Cell Biology

Circulating Exosomal MiR-107 Restrains Tumorigenesis in Diffuse Large B-Cell Lymphoma by Targeting 14-3-3η

Jiarui Liu et al.

Summary: The downregulation of exosomal miR-107 in DLBCL patients is associated with disease progression and may serve as a potential diagnostic and prognostic indicator for DLBCL. MiR-107 plays a crucial role in lymphomagenesis and could be a new therapeutic target for DLBCL management.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Hematology

MiR-22, a serum predictor of poor outcome and therapy response in diffuse large B-cell lymphoma patients

Federica Rinaldi et al.

Summary: DLBCL is a challenging neoplasm and miR-22 may serve as a promising prognostic/predictive biomarker, linked to therapy response.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Review Oncology

Treatment resistance in diffuse large B-cell lymphoma

Michael Y. He et al.

Summary: Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous disease and the most common subtype of lymphoma. While some patients can be cured, many still experience treatment resistance and poor clinical outcomes. Efforts to improve standard treatments have often been unsuccessful, highlighting the pressing need to understand and manage treatment resistance.

LEUKEMIA (2021)

Review Pharmacology & Pharmacy

Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?

Nik Nur Syazana Binti Nik Mohamed Kamal et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Oncology

New agents and regimens for diffuse large B cell lymphoma

Liang Wang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression

Enli Yang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Oncology

Extracellular vesicles in hematological malignancies

Zofia Litwinska et al.

LEUKEMIA & LYMPHOMA (2019)

Article Biochemistry & Molecular Biology

Reassessment of Exosome Composition

Dennis K. Jeppesen et al.

Article Biochemistry & Molecular Biology

Focus on exosomes-From pathogenic mechanisms to the potential clinical application value in lymphoma

Jiarui Liu et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Article Hematology

Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment

Yang Liu et al.

AMERICAN JOURNAL OF HEMATOLOGY (2019)

Review Oncology

Extracellular vesicles in cancer - implications for future improvements in cancer care

Rong Xu et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Review Pathology

Diffuse large B-cell lymphoma

Shaoying Li et al.

PATHOLOGY (2018)

Review Genetics & Heredity

Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function

Jian Zhang et al.

GENOMICS PROTEOMICS & BIOINFORMATICS (2015)

Article Biochemistry & Molecular Biology

miRNA in Plasma Exosome is Stable under Different Storage Conditions

Qinyu Ge et al.

MOLECULES (2014)

Review Medicine, General & Internal

Diagnosis and treatment of diffuse large B-cell lymphoma

Ulrich Mey et al.

SWISS MEDICAL WEEKLY (2012)